Last updated: 11/07/2018 17:25:15
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Evaluation of LAMICTAL (lamotrigine) in Adult Subjects with HIV-Associated Peripheral Neuropathy
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Evaluation of LAMICTAL (lamotrigine) in Adult Subjects with HIV-Associated Peripheral Neuropathy
Trial description: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Evaluation of LAMICTAL (lamotrigine) in Adult Subjects with HIV-Associated Peripheral Neuropathy
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: Peripheral neuropathy associated with hiv and arv: update on diagnosis and management. Simpson, David M and McArthur, J C American Association for the Advancement of Science Annual Meeting and Science Innovation Exposition 2/12/2004 Seattle, WA; USA
Abstract: Peripheral neuropathy associated with hiv and arv: update on diagnosis and management. David M Simpson and J C McArthur 11th Annual Conference on Retroviruses and Opportunistic Infections 2/8/2004 San Francisco, CA; USA
Simpson DM, Mc ArthurJC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies. A placebo-controlled trial. Neurology 2003:60:1508-14.
Medical condition
Peripheral Neuropathies
Product
lamotrigine
Collaborators
Not applicable
Study date(s)
September 1999 to February 2001
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2001-21-02
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website